nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—ADRB2—prostate cancer	0.509	1	CbGaD
Pindolol—CYP2D6—Bicalutamide—prostate cancer	0.0378	0.505	CbGbCtD
Pindolol—CYP2D6—Abiraterone—prostate cancer	0.0314	0.418	CbGbCtD
Pindolol—CYP2D6—Doxorubicin—prostate cancer	0.0058	0.0773	CbGbCtD
Pindolol—Levobunolol—ADRB2—prostate cancer	0.000642	0.0775	CrCbGaD
Pindolol—Acebutolol—SLC22A1—prostate cancer	0.000614	0.0741	CrCbGaD
Pindolol—Metipranolol—ADRB2—prostate cancer	0.000612	0.0739	CrCbGaD
Pindolol—Carteolol—ADRB2—prostate cancer	0.000546	0.0659	CrCbGaD
Pindolol—Nadolol—ADRB2—prostate cancer	0.000486	0.0587	CrCbGaD
Pindolol—Esmolol—ADRB2—prostate cancer	0.000486	0.0587	CrCbGaD
Pindolol—Bupranolol—ADRB2—prostate cancer	0.000464	0.056	CrCbGaD
Pindolol—Betaxolol—ADRB2—prostate cancer	0.000428	0.0517	CrCbGaD
Pindolol—Atenolol—ADRB2—prostate cancer	0.000424	0.0512	CrCbGaD
Pindolol—Bisoprolol—ADRB2—prostate cancer	0.000414	0.0499	CrCbGaD
Pindolol—Acebutolol—ADRB2—prostate cancer	0.000392	0.0473	CrCbGaD
Pindolol—Oxprenolol—ADRB2—prostate cancer	0.000389	0.0469	CrCbGaD
Pindolol—Alprenolol—ADRB2—prostate cancer	0.000356	0.0429	CrCbGaD
Pindolol—Metoprolol—ADRB2—prostate cancer	0.000331	0.0399	CrCbGaD
Pindolol—Metoprolol—CYP2C19—prostate cancer	0.000285	0.0343	CrCbGaD
Pindolol—Isoprenaline—ADRB2—prostate cancer	0.000235	0.0283	CrCbGaD
Pindolol—Bisoprolol—CYP3A4—prostate cancer	0.000226	0.0273	CrCbGaD
Pindolol—Propranolol—CYP3A5—prostate cancer	0.000211	0.0255	CrCbGaD
Pindolol—Isoprenaline—CYP1A1—prostate cancer	0.000201	0.0243	CrCbGaD
Pindolol—Abdominal pain—Mitoxantrone—prostate cancer	0.000179	0.000586	CcSEcCtD
Pindolol—Muscle spasms—Capecitabine—prostate cancer	0.000179	0.000585	CcSEcCtD
Pindolol—Hypotension—Etoposide—prostate cancer	0.000176	0.000576	CcSEcCtD
Pindolol—Asthenia—Estradiol—prostate cancer	0.000174	0.000571	CcSEcCtD
Pindolol—Tremor—Capecitabine—prostate cancer	0.000174	0.00057	CcSEcCtD
Pindolol—Angiopathy—Prednisone—prostate cancer	0.000172	0.000565	CcSEcCtD
Pindolol—Syncope—Docetaxel—prostate cancer	0.000172	0.000563	CcSEcCtD
Pindolol—Pruritus—Estradiol—prostate cancer	0.000172	0.000563	CcSEcCtD
Pindolol—Pollakiuria—Epirubicin—prostate cancer	0.000172	0.000562	CcSEcCtD
Pindolol—Palpitations—Docetaxel—prostate cancer	0.00017	0.000555	CcSEcCtD
Pindolol—Paraesthesia—Etoposide—prostate cancer	0.000169	0.000554	CcSEcCtD
Pindolol—Weight increased—Epirubicin—prostate cancer	0.000169	0.000553	CcSEcCtD
Pindolol—Loss of consciousness—Docetaxel—prostate cancer	0.000169	0.000552	CcSEcCtD
Pindolol—Dyspnoea—Etoposide—prostate cancer	0.000168	0.00055	CcSEcCtD
Pindolol—Somnolence—Etoposide—prostate cancer	0.000168	0.000548	CcSEcCtD
Pindolol—Vertigo—Capecitabine—prostate cancer	0.000167	0.000546	CcSEcCtD
Pindolol—Propranolol—ADRB2—prostate cancer	0.000167	0.0201	CrCbGaD
Pindolol—Syncope—Capecitabine—prostate cancer	0.000167	0.000545	CcSEcCtD
Pindolol—Mental disorder—Prednisone—prostate cancer	0.000167	0.000545	CcSEcCtD
Pindolol—Diarrhoea—Estradiol—prostate cancer	0.000166	0.000545	CcSEcCtD
Pindolol—Drowsiness—Epirubicin—prostate cancer	0.000166	0.000542	CcSEcCtD
Pindolol—Palpitations—Capecitabine—prostate cancer	0.000164	0.000537	CcSEcCtD
Pindolol—Myalgia—Docetaxel—prostate cancer	0.000163	0.000535	CcSEcCtD
Pindolol—Chest pain—Docetaxel—prostate cancer	0.000163	0.000535	CcSEcCtD
Pindolol—Arthralgia—Docetaxel—prostate cancer	0.000163	0.000535	CcSEcCtD
Pindolol—Loss of consciousness—Capecitabine—prostate cancer	0.000163	0.000535	CcSEcCtD
Pindolol—Gastrointestinal disorder—Etoposide—prostate cancer	0.000163	0.000533	CcSEcCtD
Pindolol—Asthenia—Mitoxantrone—prostate cancer	0.000163	0.000532	CcSEcCtD
Pindolol—Fatigue—Etoposide—prostate cancer	0.000162	0.000532	CcSEcCtD
Pindolol—Constipation—Etoposide—prostate cancer	0.000161	0.000528	CcSEcCtD
Pindolol—Pain—Etoposide—prostate cancer	0.000161	0.000528	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—prostate cancer	0.000161	0.000527	CcSEcCtD
Pindolol—Dizziness—Estradiol—prostate cancer	0.000161	0.000526	CcSEcCtD
Pindolol—Dry mouth—Docetaxel—prostate cancer	0.00016	0.000523	CcSEcCtD
Pindolol—Sweating—Epirubicin—prostate cancer	0.000159	0.00052	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—prostate cancer	0.000159	0.00052	CcSEcCtD
Pindolol—Arthralgia—Capecitabine—prostate cancer	0.000158	0.000518	CcSEcCtD
Pindolol—Chest pain—Capecitabine—prostate cancer	0.000158	0.000518	CcSEcCtD
Pindolol—Myalgia—Capecitabine—prostate cancer	0.000158	0.000518	CcSEcCtD
Pindolol—Confusional state—Docetaxel—prostate cancer	0.000158	0.000517	CcSEcCtD
Pindolol—Anxiety—Capecitabine—prostate cancer	0.000158	0.000516	CcSEcCtD
Pindolol—Oedema—Docetaxel—prostate cancer	0.000157	0.000513	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—prostate cancer	0.000156	0.000512	CcSEcCtD
Pindolol—Feeling abnormal—Etoposide—prostate cancer	0.000155	0.000508	CcSEcCtD
Pindolol—Diarrhoea—Mitoxantrone—prostate cancer	0.000155	0.000507	CcSEcCtD
Pindolol—Dry mouth—Capecitabine—prostate cancer	0.000155	0.000506	CcSEcCtD
Pindolol—Vomiting—Estradiol—prostate cancer	0.000155	0.000506	CcSEcCtD
Pindolol—Gastrointestinal pain—Etoposide—prostate cancer	0.000154	0.000504	CcSEcCtD
Pindolol—Shock—Docetaxel—prostate cancer	0.000154	0.000504	CcSEcCtD
Pindolol—Nervous system disorder—Docetaxel—prostate cancer	0.000154	0.000503	CcSEcCtD
Pindolol—Rash—Estradiol—prostate cancer	0.000153	0.000502	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—prostate cancer	0.000153	0.000502	CcSEcCtD
Pindolol—Dermatitis—Estradiol—prostate cancer	0.000153	0.000501	CcSEcCtD
Pindolol—Confusional state—Capecitabine—prostate cancer	0.000153	0.0005	CcSEcCtD
Pindolol—Tachycardia—Docetaxel—prostate cancer	0.000153	0.0005	CcSEcCtD
Pindolol—Headache—Estradiol—prostate cancer	0.000152	0.000499	CcSEcCtD
Pindolol—Oedema—Capecitabine—prostate cancer	0.000152	0.000496	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—prostate cancer	0.000151	0.000495	CcSEcCtD
Pindolol—Shock—Capecitabine—prostate cancer	0.000149	0.000488	CcSEcCtD
Pindolol—Abdominal pain—Etoposide—prostate cancer	0.000149	0.000488	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—prostate cancer	0.000149	0.000488	CcSEcCtD
Pindolol—Nervous system disorder—Capecitabine—prostate cancer	0.000149	0.000487	CcSEcCtD
Pindolol—Vertigo—Prednisone—prostate cancer	0.000149	0.000487	CcSEcCtD
Pindolol—Syncope—Prednisone—prostate cancer	0.000148	0.000486	CcSEcCtD
Pindolol—Tachycardia—Capecitabine—prostate cancer	0.000148	0.000484	CcSEcCtD
Pindolol—Sweating—Doxorubicin—prostate cancer	0.000147	0.000481	CcSEcCtD
Pindolol—Hyperhidrosis—Capecitabine—prostate cancer	0.000147	0.00048	CcSEcCtD
Pindolol—Hypotension—Docetaxel—prostate cancer	0.000146	0.000479	CcSEcCtD
Pindolol—Loss of consciousness—Prednisone—prostate cancer	0.000145	0.000476	CcSEcCtD
Pindolol—Nausea—Estradiol—prostate cancer	0.000144	0.000473	CcSEcCtD
Pindolol—Vomiting—Mitoxantrone—prostate cancer	0.000144	0.000472	CcSEcCtD
Pindolol—Propranolol—CYP2C19—prostate cancer	0.000144	0.0173	CrCbGaD
Pindolol—Visual impairment—Epirubicin—prostate cancer	0.000143	0.000469	CcSEcCtD
Pindolol—Propranolol—CYP1A1—prostate cancer	0.000143	0.0173	CrCbGaD
Pindolol—Rash—Mitoxantrone—prostate cancer	0.000143	0.000468	CcSEcCtD
Pindolol—Dermatitis—Mitoxantrone—prostate cancer	0.000143	0.000467	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000143	0.000467	CcSEcCtD
Pindolol—Headache—Mitoxantrone—prostate cancer	0.000142	0.000465	CcSEcCtD
Pindolol—Hypotension—Capecitabine—prostate cancer	0.000142	0.000464	CcSEcCtD
Pindolol—Insomnia—Docetaxel—prostate cancer	0.000142	0.000464	CcSEcCtD
Pindolol—Myalgia—Prednisone—prostate cancer	0.000141	0.000461	CcSEcCtD
Pindolol—Arthralgia—Prednisone—prostate cancer	0.000141	0.000461	CcSEcCtD
Pindolol—Paraesthesia—Docetaxel—prostate cancer	0.000141	0.00046	CcSEcCtD
Pindolol—Anxiety—Prednisone—prostate cancer	0.00014	0.00046	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—prostate cancer	0.00014	0.000458	CcSEcCtD
Pindolol—Dyspnoea—Docetaxel—prostate cancer	0.00014	0.000457	CcSEcCtD
Pindolol—Somnolence—Docetaxel—prostate cancer	0.000139	0.000456	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—prostate cancer	0.000139	0.000454	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000138	0.000452	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—prostate cancer	0.000138	0.000452	CcSEcCtD
Pindolol—Dyspepsia—Docetaxel—prostate cancer	0.000138	0.000451	CcSEcCtD
Pindolol—Insomnia—Capecitabine—prostate cancer	0.000137	0.000449	CcSEcCtD
Pindolol—Paraesthesia—Capecitabine—prostate cancer	0.000136	0.000446	CcSEcCtD
Pindolol—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000135	0.000443	CcSEcCtD
Pindolol—Asthenia—Etoposide—prostate cancer	0.000135	0.000443	CcSEcCtD
Pindolol—Dyspnoea—Capecitabine—prostate cancer	0.000135	0.000443	CcSEcCtD
Pindolol—Oedema—Prednisone—prostate cancer	0.000135	0.000442	CcSEcCtD
Pindolol—Fatigue—Docetaxel—prostate cancer	0.000135	0.000442	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—prostate cancer	0.000135	0.000442	CcSEcCtD
Pindolol—Nausea—Mitoxantrone—prostate cancer	0.000135	0.000441	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—prostate cancer	0.000134	0.000439	CcSEcCtD
Pindolol—Constipation—Docetaxel—prostate cancer	0.000134	0.000438	CcSEcCtD
Pindolol—Pain—Docetaxel—prostate cancer	0.000134	0.000438	CcSEcCtD
Pindolol—Dyspepsia—Capecitabine—prostate cancer	0.000133	0.000437	CcSEcCtD
Pindolol—Pruritus—Etoposide—prostate cancer	0.000133	0.000436	CcSEcCtD
Pindolol—Shock—Prednisone—prostate cancer	0.000133	0.000435	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—prostate cancer	0.000133	0.000434	CcSEcCtD
Pindolol—Nervous system disorder—Prednisone—prostate cancer	0.000132	0.000434	CcSEcCtD
Pindolol—Tachycardia—Prednisone—prostate cancer	0.000132	0.000432	CcSEcCtD
Pindolol—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000131	0.000429	CcSEcCtD
Pindolol—Fatigue—Capecitabine—prostate cancer	0.000131	0.000428	CcSEcCtD
Pindolol—Hyperhidrosis—Prednisone—prostate cancer	0.000131	0.000427	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—prostate cancer	0.00013	0.000426	CcSEcCtD
Pindolol—Pain—Capecitabine—prostate cancer	0.00013	0.000424	CcSEcCtD
Pindolol—Constipation—Capecitabine—prostate cancer	0.00013	0.000424	CcSEcCtD
Pindolol—Feeling abnormal—Docetaxel—prostate cancer	0.000129	0.000422	CcSEcCtD
Pindolol—Diarrhoea—Etoposide—prostate cancer	0.000129	0.000422	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—prostate cancer	0.000128	0.00042	CcSEcCtD
Pindolol—Gastrointestinal pain—Docetaxel—prostate cancer	0.000128	0.000419	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—prostate cancer	0.000128	0.000418	CcSEcCtD
Pindolol—Flatulence—Epirubicin—prostate cancer	0.000128	0.000418	CcSEcCtD
Pindolol—Tension—Epirubicin—prostate cancer	0.000127	0.000416	CcSEcCtD
Pindolol—Nervousness—Epirubicin—prostate cancer	0.000126	0.000412	CcSEcCtD
Pindolol—Feeling abnormal—Capecitabine—prostate cancer	0.000125	0.000409	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—prostate cancer	0.000125	0.000409	CcSEcCtD
Pindolol—Dizziness—Etoposide—prostate cancer	0.000125	0.000408	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—prostate cancer	0.000124	0.000407	CcSEcCtD
Pindolol—Gastrointestinal pain—Capecitabine—prostate cancer	0.000124	0.000406	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—prostate cancer	0.000124	0.000406	CcSEcCtD
Pindolol—Abdominal pain—Docetaxel—prostate cancer	0.000124	0.000405	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000123	0.000403	CcSEcCtD
Pindolol—Insomnia—Prednisone—prostate cancer	0.000122	0.0004	CcSEcCtD
Pindolol—Paraesthesia—Prednisone—prostate cancer	0.000121	0.000397	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—prostate cancer	0.000121	0.000395	CcSEcCtD
Pindolol—Abdominal pain—Capecitabine—prostate cancer	0.00012	0.000392	CcSEcCtD
Pindolol—Vomiting—Etoposide—prostate cancer	0.00012	0.000392	CcSEcCtD
Pindolol—Dyspepsia—Prednisone—prostate cancer	0.000119	0.000389	CcSEcCtD
Pindolol—Rash—Etoposide—prostate cancer	0.000119	0.000389	CcSEcCtD
Pindolol—Dermatitis—Etoposide—prostate cancer	0.000119	0.000389	CcSEcCtD
Pindolol—Headache—Etoposide—prostate cancer	0.000118	0.000386	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—prostate cancer	0.000118	0.000386	CcSEcCtD
Pindolol—Tension—Doxorubicin—prostate cancer	0.000118	0.000385	CcSEcCtD
Pindolol—Fatigue—Prednisone—prostate cancer	0.000116	0.000381	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—prostate cancer	0.000116	0.000381	CcSEcCtD
Pindolol—Vertigo—Epirubicin—prostate cancer	0.000116	0.000381	CcSEcCtD
Pindolol—Syncope—Epirubicin—prostate cancer	0.000116	0.00038	CcSEcCtD
Pindolol—Constipation—Prednisone—prostate cancer	0.000116	0.000378	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—prostate cancer	0.000115	0.000377	CcSEcCtD
Pindolol—Palpitations—Epirubicin—prostate cancer	0.000114	0.000374	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—prostate cancer	0.000114	0.000372	CcSEcCtD
Pindolol—Asthenia—Docetaxel—prostate cancer	0.000112	0.000368	CcSEcCtD
Pindolol—Nausea—Etoposide—prostate cancer	0.000112	0.000366	CcSEcCtD
Pindolol—Feeling abnormal—Prednisone—prostate cancer	0.000111	0.000364	CcSEcCtD
Pindolol—Pruritus—Docetaxel—prostate cancer	0.000111	0.000363	CcSEcCtD
Pindolol—Gastrointestinal pain—Prednisone—prostate cancer	0.00011	0.000362	CcSEcCtD
Pindolol—Chest pain—Epirubicin—prostate cancer	0.00011	0.000361	CcSEcCtD
Pindolol—Myalgia—Epirubicin—prostate cancer	0.00011	0.000361	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—prostate cancer	0.00011	0.000361	CcSEcCtD
Pindolol—Anxiety—Epirubicin—prostate cancer	0.00011	0.000359	CcSEcCtD
Pindolol—Asthenia—Capecitabine—prostate cancer	0.000109	0.000356	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—prostate cancer	0.000108	0.000353	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—prostate cancer	0.000108	0.000352	CcSEcCtD
Pindolol—Syncope—Doxorubicin—prostate cancer	0.000107	0.000352	CcSEcCtD
Pindolol—Pruritus—Capecitabine—prostate cancer	0.000107	0.000351	CcSEcCtD
Pindolol—Diarrhoea—Docetaxel—prostate cancer	0.000107	0.000351	CcSEcCtD
Pindolol—Abdominal pain—Prednisone—prostate cancer	0.000107	0.00035	CcSEcCtD
Pindolol—Confusional state—Epirubicin—prostate cancer	0.000107	0.000349	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—prostate cancer	0.000106	0.000346	CcSEcCtD
Pindolol—Oedema—Epirubicin—prostate cancer	0.000106	0.000346	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—prostate cancer	0.000105	0.000345	CcSEcCtD
Pindolol—Shock—Epirubicin—prostate cancer	0.000104	0.00034	CcSEcCtD
Pindolol—Diarrhoea—Capecitabine—prostate cancer	0.000104	0.00034	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—prostate cancer	0.000104	0.000339	CcSEcCtD
Pindolol—Dizziness—Docetaxel—prostate cancer	0.000104	0.000339	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—prostate cancer	0.000103	0.000337	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—prostate cancer	0.000102	0.000334	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—prostate cancer	0.000102	0.000334	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—prostate cancer	0.000102	0.000334	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—prostate cancer	0.000102	0.000334	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—prostate cancer	0.000102	0.000333	CcSEcCtD
Pindolol—Dizziness—Capecitabine—prostate cancer	0.0001	0.000328	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—prostate cancer	9.97e-05	0.000326	CcSEcCtD
Pindolol—Vomiting—Docetaxel—prostate cancer	9.96e-05	0.000326	CcSEcCtD
Pindolol—Rash—Docetaxel—prostate cancer	9.88e-05	0.000323	CcSEcCtD
Pindolol—Hypotension—Epirubicin—prostate cancer	9.87e-05	0.000323	CcSEcCtD
Pindolol—Dermatitis—Docetaxel—prostate cancer	9.87e-05	0.000323	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—prostate cancer	9.86e-05	0.000323	CcSEcCtD
Pindolol—Headache—Docetaxel—prostate cancer	9.81e-05	0.000321	CcSEcCtD
Pindolol—Oedema—Doxorubicin—prostate cancer	9.77e-05	0.00032	CcSEcCtD
Pindolol—Asthenia—Prednisone—prostate cancer	9.69e-05	0.000317	CcSEcCtD
Pindolol—Vomiting—Capecitabine—prostate cancer	9.64e-05	0.000316	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—prostate cancer	9.62e-05	0.000315	CcSEcCtD
Pindolol—Shock—Doxorubicin—prostate cancer	9.62e-05	0.000315	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—prostate cancer	9.59e-05	0.000314	CcSEcCtD
Pindolol—Rash—Capecitabine—prostate cancer	9.56e-05	0.000313	CcSEcCtD
Pindolol—Pruritus—Prednisone—prostate cancer	9.56e-05	0.000313	CcSEcCtD
Pindolol—Insomnia—Epirubicin—prostate cancer	9.55e-05	0.000313	CcSEcCtD
Pindolol—Dermatitis—Capecitabine—prostate cancer	9.55e-05	0.000313	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—prostate cancer	9.54e-05	0.000312	CcSEcCtD
Pindolol—Headache—Capecitabine—prostate cancer	9.5e-05	0.000311	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—prostate cancer	9.49e-05	0.000311	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—prostate cancer	9.45e-05	0.000309	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—prostate cancer	9.42e-05	0.000308	CcSEcCtD
Pindolol—Somnolence—Epirubicin—prostate cancer	9.39e-05	0.000307	CcSEcCtD
Pindolol—Nausea—Docetaxel—prostate cancer	9.3e-05	0.000305	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—prostate cancer	9.3e-05	0.000304	CcSEcCtD
Pindolol—Diarrhoea—Prednisone—prostate cancer	9.24e-05	0.000303	CcSEcCtD
Pindolol—Propranolol—CYP3A4—prostate cancer	9.13e-05	0.011	CrCbGaD
Pindolol—Hypotension—Doxorubicin—prostate cancer	9.13e-05	0.000299	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—prostate cancer	9.12e-05	0.000299	CcSEcCtD
Pindolol—Fatigue—Epirubicin—prostate cancer	9.11e-05	0.000298	CcSEcCtD
Pindolol—Pain—Epirubicin—prostate cancer	9.03e-05	0.000296	CcSEcCtD
Pindolol—Constipation—Epirubicin—prostate cancer	9.03e-05	0.000296	CcSEcCtD
Pindolol—Nausea—Capecitabine—prostate cancer	9.01e-05	0.000295	CcSEcCtD
Pindolol—Dizziness—Prednisone—prostate cancer	8.93e-05	0.000292	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	8.91e-05	0.000292	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—prostate cancer	8.84e-05	0.000289	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—prostate cancer	8.78e-05	0.000287	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—prostate cancer	8.71e-05	0.000285	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—prostate cancer	8.71e-05	0.000285	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—prostate cancer	8.69e-05	0.000284	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—prostate cancer	8.64e-05	0.000283	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—prostate cancer	8.6e-05	0.000282	CcSEcCtD
Pindolol—Vomiting—Prednisone—prostate cancer	8.59e-05	0.000281	CcSEcCtD
Pindolol—Rash—Prednisone—prostate cancer	8.52e-05	0.000279	CcSEcCtD
Pindolol—Dermatitis—Prednisone—prostate cancer	8.51e-05	0.000279	CcSEcCtD
Pindolol—Headache—Prednisone—prostate cancer	8.46e-05	0.000277	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.44e-05	0.000276	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—prostate cancer	8.43e-05	0.000276	CcSEcCtD
Pindolol—Constipation—Doxorubicin—prostate cancer	8.36e-05	0.000274	CcSEcCtD
Pindolol—Pain—Doxorubicin—prostate cancer	8.36e-05	0.000274	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—prostate cancer	8.35e-05	0.000273	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—prostate cancer	8.05e-05	0.000264	CcSEcCtD
Pindolol—Nausea—Prednisone—prostate cancer	8.02e-05	0.000263	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—prostate cancer	7.99e-05	0.000262	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—prostate cancer	7.73e-05	0.000253	CcSEcCtD
Pindolol—Asthenia—Epirubicin—prostate cancer	7.58e-05	0.000248	CcSEcCtD
Pindolol—Pruritus—Epirubicin—prostate cancer	7.47e-05	0.000245	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—prostate cancer	7.23e-05	0.000237	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—prostate cancer	7.01e-05	0.00023	CcSEcCtD
Pindolol—Dizziness—Epirubicin—prostate cancer	6.99e-05	0.000229	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—prostate cancer	6.92e-05	0.000226	CcSEcCtD
Pindolol—Vomiting—Epirubicin—prostate cancer	6.72e-05	0.00022	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—prostate cancer	6.69e-05	0.000219	CcSEcCtD
Pindolol—Rash—Epirubicin—prostate cancer	6.66e-05	0.000218	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—prostate cancer	6.65e-05	0.000218	CcSEcCtD
Pindolol—Headache—Epirubicin—prostate cancer	6.62e-05	0.000217	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—prostate cancer	6.46e-05	0.000212	CcSEcCtD
Pindolol—Nausea—Epirubicin—prostate cancer	6.27e-05	0.000205	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—prostate cancer	6.21e-05	0.000203	CcSEcCtD
Pindolol—Rash—Doxorubicin—prostate cancer	6.16e-05	0.000202	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—prostate cancer	6.16e-05	0.000202	CcSEcCtD
Pindolol—Headache—Doxorubicin—prostate cancer	6.12e-05	0.0002	CcSEcCtD
Pindolol—Nausea—Doxorubicin—prostate cancer	5.81e-05	0.00019	CcSEcCtD
Pindolol—HTR1A—Signaling Pathways—FGFR2—prostate cancer	1.13e-05	0.00011	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—IL6—prostate cancer	1.12e-05	0.00011	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.12e-05	0.000109	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CREBBP—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TERT—prostate cancer	1.11e-05	0.000108	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCND1—prostate cancer	1.1e-05	0.000108	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IGF1—prostate cancer	1.1e-05	0.000107	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CTNNB1—prostate cancer	1.09e-05	0.000107	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—prostate cancer	1.09e-05	0.000107	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL2—prostate cancer	1.09e-05	0.000106	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TERT—prostate cancer	1.08e-05	0.000106	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	1.08e-05	0.000106	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—prostate cancer	1.07e-05	0.000105	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CDKN1A—prostate cancer	1.07e-05	0.000104	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NCOA2—prostate cancer	1.07e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PTEN—prostate cancer	1.06e-05	0.000104	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MAP2K1—prostate cancer	1.06e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	1.06e-05	0.000104	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LEP—prostate cancer	1.06e-05	0.000103	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CD—prostate cancer	1.05e-05	0.000103	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	1.05e-05	0.000102	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PIK3CA—prostate cancer	1.04e-05	0.000102	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SERPINE1—prostate cancer	1.04e-05	0.000102	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—prostate cancer	1.04e-05	0.000102	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HIF1A—prostate cancer	1.04e-05	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KDR—prostate cancer	1.03e-05	0.000101	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LEP—prostate cancer	1.03e-05	0.000101	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—KRAS—prostate cancer	1.03e-05	0.000101	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	1.02e-05	0.0001	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC5A5—prostate cancer	1.02e-05	9.95e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EP300—prostate cancer	1.01e-05	9.93e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KDR—prostate cancer	1.01e-05	9.91e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LEP—prostate cancer	1.01e-05	9.89e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	1.01e-05	9.87e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FGF2—prostate cancer	1.01e-05	9.86e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CAV1—prostate cancer	1e-05	9.8e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOS3—prostate cancer	9.94e-06	9.73e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP2E1—prostate cancer	9.92e-06	9.72e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KDR—prostate cancer	9.9e-06	9.69e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	9.87e-06	9.66e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SRC—prostate cancer	9.86e-06	9.65e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—BAD—prostate cancer	9.84e-06	9.64e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NQO1—prostate cancer	9.81e-06	9.61e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TH—prostate cancer	9.67e-06	9.47e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—JAK2—prostate cancer	9.66e-06	9.45e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ESR1—prostate cancer	9.65e-06	9.44e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—BAD—prostate cancer	9.63e-06	9.43e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—prostate cancer	9.61e-06	9.4e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP3A4—prostate cancer	9.57e-06	9.37e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APC—prostate cancer	9.53e-06	9.33e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	9.53e-06	9.33e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—STAT3—prostate cancer	9.51e-06	9.31e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CA—prostate cancer	9.46e-06	9.27e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MDM2—prostate cancer	9.43e-06	9.23e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGF—prostate cancer	9.42e-06	9.22e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	9.42e-06	9.22e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—BAD—prostate cancer	9.42e-06	9.22e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1B1—prostate cancer	9.41e-06	9.21e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	9.33e-06	9.13e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APC—prostate cancer	9.33e-06	9.13e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ERBB2—prostate cancer	9.29e-06	9.1e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGF—prostate cancer	9.22e-06	9.02e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	9.22e-06	9.02e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CB—prostate cancer	9.17e-06	8.98e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	9.15e-06	8.96e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APC—prostate cancer	9.12e-06	8.93e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CG—prostate cancer	9.12e-06	8.93e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GGT1—prostate cancer	9.11e-06	8.92e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—INS—prostate cancer	9.02e-06	8.83e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGF—prostate cancer	9.01e-06	8.82e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IRS1—prostate cancer	9.01e-06	8.82e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NCOA1—prostate cancer	8.98e-06	8.79e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	8.95e-06	8.76e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP19A1—prostate cancer	8.85e-06	8.66e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	8.84e-06	8.65e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MYC—prostate cancer	8.84e-06	8.65e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—INS—prostate cancer	8.83e-06	8.64e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFB1—prostate cancer	8.82e-06	8.63e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL8—prostate cancer	8.81e-06	8.63e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GSK3B—prostate cancer	8.75e-06	8.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	8.73e-06	8.54e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	8.69e-06	8.5e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	8.65e-06	8.46e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—prostate cancer	8.64e-06	8.46e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—INS—prostate cancer	8.63e-06	8.45e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1B—prostate cancer	8.61e-06	8.43e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	8.54e-06	8.36e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—RXRA—prostate cancer	8.54e-06	8.36e-05	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—prostate cancer	8.51e-06	8.34e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	8.5e-06	8.32e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CREBBP—prostate cancer	8.45e-06	8.28e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CASP3—prostate cancer	8.44e-06	8.26e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	8.44e-06	8.26e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL2—prostate cancer	8.42e-06	8.25e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—prostate cancer	8.38e-06	8.2e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	8.38e-06	8.2e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF1—prostate cancer	8.35e-06	8.17e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—prostate cancer	8.31e-06	8.13e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	8.3e-06	8.13e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	8.29e-06	8.11e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	8.25e-06	8.08e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—COMT—prostate cancer	8.22e-06	8.05e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—prostate cancer	8.21e-06	8.04e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	8.2e-06	8.03e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	8.2e-06	8.03e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTP1—prostate cancer	8.18e-06	8.01e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KRAS—prostate cancer	8.17e-06	7.99e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CTNNB1—prostate cancer	8.13e-06	7.96e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	8.12e-06	7.95e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	8.11e-06	7.94e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MAP2K1—prostate cancer	8.07e-06	7.9e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ITPR1—prostate cancer	8.05e-06	7.88e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	8.03e-06	7.86e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	8.02e-06	7.86e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CD—prostate cancer	8.02e-06	7.85e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—prostate cancer	7.97e-06	7.8e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1A—prostate cancer	7.94e-06	7.78e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CA—prostate cancer	7.94e-06	7.77e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SERPINE1—prostate cancer	7.93e-06	7.76e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PTEN—prostate cancer	7.93e-06	7.76e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	7.91e-06	7.75e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	7.85e-06	7.68e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—KRAS—prostate cancer	7.85e-06	7.68e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	7.74e-06	7.58e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—prostate cancer	7.73e-06	7.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	7.69e-06	7.53e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FGF2—prostate cancer	7.68e-06	7.51e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TYMS—prostate cancer	7.61e-06	7.45e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOS3—prostate cancer	7.57e-06	7.41e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EP300—prostate cancer	7.56e-06	7.4e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	7.54e-06	7.38e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	7.52e-06	7.37e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—prostate cancer	7.52e-06	7.36e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	7.51e-06	7.35e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CA—prostate cancer	7.5e-06	7.34e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	7.4e-06	7.25e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LPL—prostate cancer	7.38e-06	7.23e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	7.37e-06	7.22e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JAK2—prostate cancer	7.36e-06	7.2e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SRC—prostate cancer	7.35e-06	7.2e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	7.34e-06	7.19e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	7.3e-06	7.15e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—prostate cancer	7.26e-06	7.11e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	7.24e-06	7.09e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	7.21e-06	7.06e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MDM2—prostate cancer	7.18e-06	7.03e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—prostate cancer	7.16e-06	7.01e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	7.15e-06	7e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1A1—prostate cancer	7.13e-06	6.98e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—STAT3—prostate cancer	7.09e-06	6.94e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ERBB2—prostate cancer	7.08e-06	6.93e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ERCC2—prostate cancer	7.07e-06	6.92e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	7.02e-06	6.87e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	6.99e-06	6.84e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	6.87e-06	6.72e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	6.86e-06	6.71e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	6.78e-06	6.64e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	6.72e-06	6.58e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL8—prostate cancer	6.71e-06	6.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL2—prostate cancer	6.71e-06	6.57e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	6.71e-06	6.56e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	6.67e-06	6.53e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTHFR—prostate cancer	6.65e-06	6.51e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—prostate cancer	6.64e-06	6.5e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	6.63e-06	6.49e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MYC—prostate cancer	6.59e-06	6.45e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	6.57e-06	6.43e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFB1—prostate cancer	6.57e-06	6.43e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL2—prostate cancer	6.56e-06	6.42e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	6.56e-06	6.42e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	6.54e-06	6.4e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	6.53e-06	6.39e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARA—prostate cancer	6.52e-06	6.38e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	6.49e-06	6.35e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	6.48e-06	6.34e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—prostate cancer	6.44e-06	6.31e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CASP3—prostate cancer	6.43e-06	6.29e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL2—prostate cancer	6.42e-06	6.28e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	6.4e-06	6.26e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—prostate cancer	6.38e-06	6.25e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	6.35e-06	6.22e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	6.34e-06	6.2e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	6.33e-06	6.19e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	6.31e-06	6.18e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—prostate cancer	6.26e-06	6.12e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	6.21e-06	6.08e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	6.19e-06	6.06e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	6.19e-06	6.06e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	6.17e-06	6.04e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	6.16e-06	6.03e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CAV1—prostate cancer	6.13e-06	6e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—prostate cancer	6.13e-06	6e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KRAS—prostate cancer	6.09e-06	5.96e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—prostate cancer	6.07e-06	5.95e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	6.05e-06	5.92e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTEN—prostate cancer	6.04e-06	5.91e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	6.02e-06	5.9e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EP300—prostate cancer	6.02e-06	5.89e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—prostate cancer	5.89e-06	5.77e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EP300—prostate cancer	5.89e-06	5.76e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SRC—prostate cancer	5.85e-06	5.73e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EP300—prostate cancer	5.76e-06	5.64e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SRC—prostate cancer	5.73e-06	5.61e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	5.7e-06	5.58e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	5.65e-06	5.53e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SRC—prostate cancer	5.6e-06	5.48e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	5.59e-06	5.47e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CG—prostate cancer	5.58e-06	5.47e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	5.58e-06	5.46e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	5.52e-06	5.41e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—prostate cancer	5.45e-06	5.34e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—prostate cancer	5.41e-06	5.3e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—STAT3—prostate cancer	5.4e-06	5.29e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—INS—prostate cancer	5.29e-06	5.18e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MYC—prostate cancer	5.25e-06	5.14e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	5.23e-06	5.12e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CREBBP—prostate cancer	5.18e-06	5.07e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MYC—prostate cancer	5.13e-06	5.02e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	5.13e-06	5.02e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	5.12e-06	5.01e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	5.02e-06	4.91e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MYC—prostate cancer	5.02e-06	4.91e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFB1—prostate cancer	5.01e-06	4.9e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—prostate cancer	4.95e-06	4.85e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CD—prostate cancer	4.91e-06	4.81e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—prostate cancer	4.91e-06	4.8e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	4.85e-06	4.74e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	4.74e-06	4.64e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NOS3—prostate cancer	4.64e-06	4.54e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KRAS—prostate cancer	4.64e-06	4.54e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—prostate cancer	4.57e-06	4.47e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	4.45e-06	4.36e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	4.36e-06	4.26e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—prostate cancer	4.31e-06	4.22e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.28e-06	4.19e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	4.26e-06	4.17e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—prostate cancer	4.24e-06	4.15e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—prostate cancer	4.21e-06	4.13e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—prostate cancer	4.12e-06	4.03e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—prostate cancer	3.94e-06	3.86e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—prostate cancer	3.86e-06	3.78e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—prostate cancer	3.77e-06	3.69e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTEN—prostate cancer	3.7e-06	3.62e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	3.64e-06	3.56e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	3.56e-06	3.48e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—EP300—prostate cancer	3.53e-06	3.45e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—prostate cancer	3.48e-06	3.41e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.61e-06	2.55e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—prostate cancer	2.13e-06	2.09e-05	CbGpPWpGaD
